An early Phase II clinical trial with followup of tomoxetine (LY139603) in the treatment of newly admitted depressed patients.
D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use*; D000069445:Atomoxetine Hydrochloride; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011437:Propylamines / Q000627:therapeutic use*
D000928:Antidepressive Agents; D011437:Propylamines; D000069445:Atomoxetine Hydrochloride